HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sean P Marrelli Selected Research

Sean P Marrelli Research Topics

Disease

7Stroke (Strokes)
10/2023 - 11/2013
4Ischemia
04/2019 - 09/2002
3Hypothermia
12/2017 - 05/2014
2Neoplasms (Cancer)
10/2023 - 01/2018
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2023 - 10/2018
2Neuroinflammatory Diseases
11/2022 - 08/2022
2Infarction (Infarctions)
01/2021 - 04/2019
2Brain Injuries (Brain Injury)
04/2019 - 03/2008
2Ischemic Stroke
10/2018 - 01/2014
2Brain Ischemia (Cerebral Ischemia)
05/2014 - 01/2014
2Hypertension (High Blood Pressure)
10/2011 - 01/2011
1Arteriovenous Malformations (Arteriovenous Malformation)
05/2024
1Moyamoya Disease (Moya-Moya Disease)
10/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022
1Gliosis
01/2021
1Rupture
01/2020
1Hypoxia (Hypoxemia)
04/2019
1Brain Neoplasms (Brain Tumor)
01/2018
1Obesity
01/2018
1Inflammation (Inflammations)
01/2018
1Heart Arrest (Cardiac Arrest)
05/2014
1Tachycardia (Tachyarrhythmias)
11/2013
1Apnea
08/2013
1Obstructive Sleep Apnea
08/2013

Drug/Important Bio-Agent (IBA)

3Ion Channels (Ion Channel)IBA
12/2017 - 11/2013
2CytokinesIBA
10/2023 - 01/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2024
1Arginine (L-Arginine)FDA Link
10/2023
1LectinsIBA
10/2023
1Complement System Proteins (Complement)IBA
10/2023
1DNA (Deoxyribonucleic Acid)IBA
10/2023
1trimethyloxamine (trimethylamine N-oxide)IBA
11/2022
1InterferonsIBA
08/2022
1Amyloid (Amyloid Fibrils)IBA
08/2022
1Memantine (Namenda)FDA Link
01/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2021
1Silicone Elastomers (SE 30)IBA
01/2020
1BariumIBA
01/2020
1triphenyltetrazoliumIBA
04/2019
1Calcium-Calmodulin-Dependent Protein Kinase KinaseIBA
04/2019
1STO 609IBA
04/2019
1VimentinIBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018
1von Willebrand FactorIBA
10/2018
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2018
1LigandsIBA
01/2018
1dihydrocapsaicinIBA
12/2017
1carvacrolIBA
01/2015
1Transient Receptor Potential ChannelsIBA
05/2014
1salicylhydroxamic acid (SHAM)IBA
08/2013
1Purinergic P2Y2 ReceptorsIBA
08/2013
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2013
1Adenosine Triphosphate (ATP)IBA
08/2013
1rho-Associated KinasesIBA
10/2011
1Uridine Triphosphate (UTP)IBA
01/2011
1TRPC3 cation channelIBA
01/2011
1Calcium Channels (Calcium Channel)IBA
01/2011
1Neuroprotective AgentsIBA
03/2008
1ErythropoietinFDA Link
03/2008
1endothelium-dependent hyperpolarization factor (EDHF)IBA
09/2002

Therapy/Procedure

4Induced Hypothermia
04/2015 - 11/2013
1Lasers (Laser)
01/2023
1Treatment Delay
01/2021
1Ligation
04/2019
1Immunotherapy
01/2018
1Intravenous Injections
01/2018